GH (Guardant360) Bathi resik saben siji saham sajrone rolas wulan pungkasan

Guardant Health Inc (GH) - logo korporat

The implementation of Shield for colorectal cancer screening is driving sales, as confirmed by the year-over-year EPS (TTM) comparison for Guardant Health, Inc. (GH). Meanwhile, cloud-based bioinformatics outsourcing is creating IT dependency, while geopolitical sanctions are hindering global research. This chart smooths out the noise between reports, with the -14.90 metric serving as the target level for assessing earnings per share dynamics.

GH Guardant Health: Bathi resik saben saham (EPS TTM) ing interval 11.02.2024 - 15.11.2026

Guardant Corp - rincian analitis lan metrik utama (GH)

- rega saham lan prakiraan rega para ahli:
Pambiji fundamental:GH - Guardant Health
Produk asli Guardant360

Analyzing earnings per share (EPS) dynamics is critical for selecting assets with a high margin of safety. This indicator captures the annual growth rate of trailing twelve-month (TTM) net income, enabling an assessment of Guardant Health, Inc. (GH) commercialization efficiency for its oncology diagnostic tests and the success of their integration into government programs by measuring the annual EPS TTM growth.